DEBRA FONSECA: Open Payments
NPI 1073967287 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 31 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $197 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $470 |
| Amgen Inc. | 13 | $191 |
| Averitas Pharma Inc. | 2 | $71 |
| Exact Sciences Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
Products named: Wegovy, Ozempic, KRYSTEXXA, QUTENZA, OTEZLA, The Cologuard Plus Collection Kit, Rybelsus, LEQVIO.
Industry payments across TN — which companies pay providers there.
